Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.

Authors

Naomi L. Luban, George Washington UniversityFollow
Edward C.. Wong, George Washington UniversityFollow
Rodolfo Henrich Lobo
Philippe Pary
Sarah Duke

Document Type

Journal Article

Publication Date

7-1-2015

Journal

Transfusion

Volume

55

Issue

Suppl 2

Inclusive Pages

S90-S94

DOI

10.1111/trf.13089

Keywords

Anemia--chemically induced; Anemia--therapy; Erythrocyte Transfusion; Hemolysis--drug effects; Immunoglobulins, Intravenous--adverse effects; Immunologic Factors--adverse effects; Mucocutaneous Lymph Node Syndrome--drug therapy

APA Citation

Luban, N. L., Wong, E. C., Henrich Lobo, R., Pary, P., & Duke, S. (2015). Intravenous immunoglobulin–related hemolysis in patients treated for Kawasaki disease. Transfusion, 55(S2), S90-S94. doi:10.1111/trf.13089

Peer Reviewed

1